0 Comentários
0 Compartilhamentos
297 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Diabetes Drug Therapy Market Driven by Rising Global Diabetes BurdenThe Diabetes Drug Therapy Market is expanding steadily as the global incidence of diabetes continues to rise due to aging populations, increasing obesity rates, sedentary lifestyles, and changing dietary habits. Continuous pharmaceutical innovation, the development of next-generation insulin products, GLP-1 receptor agonists, SGLT2 inhibitors, and combination therapies are transforming diabetes...0 Comentários 0 Compartilhamentos 284 Visualizações 0 Anterior
-
Dipeptidyl Peptidase-4 Inhibitors Market Driven by Rising Global Diabetes BurdenThe Dipeptidyl Peptidase-4 Inhibitors Market is experiencing steady global growth as the prevalence of type 2 diabetes continues to increase across developed and emerging economies. Rising demand for effective oral glucose-lowering therapies, growing adoption of combination treatment regimens, and continuous advancements in pharmaceutical research are supporting market expansion. The...0 Comentários 0 Compartilhamentos 135 Visualizações 0 Anterior
-
Global (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile Market 2025-2034: The Chiral Pyrrolidine Intermediate Powering the Global Type 2 Diabetes Treatment PipelineGlobal (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile is a specialized chiral intermediate that has become essential in modern pharmaceutical manufacturing. This pyrrolidine-based...0 Comentários 0 Compartilhamentos 338 Visualizações 0 Anterior
-
Global Diabetic Retinopathy Market to Reach US$18.08 Billion by 2034 Amid Rising Diabetes PrevalenceThe Diabetic Retinopathy Market is witnessing steady expansion as healthcare systems intensify efforts to address diabetes-related vision impairment and blindness. The increasing global prevalence of diabetes, growing awareness regarding regular retinal screening, and technological advancements in diagnostic imaging are significantly contributing to market growth. Governments, healthcare...0 Comentários 0 Compartilhamentos 159 Visualizações 0 Anterior
-
Global Diabetic Ulcer Treatment Market to Reach US$ 13.59 Billion by 2034 Amid Rising Diabetes BurdenThe Diabetic Ulcer Treatment Market is witnessing substantial growth due to the rising global prevalence of diabetes and the increasing incidence of diabetic foot ulcers among aging populations. Diabetic ulcers are one of the most common and severe complications associated with diabetes, often leading to prolonged hospitalization, infections, and even lower-limb amputations if left untreated....0 Comentários 0 Compartilhamentos 257 Visualizações 0 Anterior
-
Global stem cell therapy for diabetes market outlook with 9.7% CAGR growth (2025–2031)According to a newly published market research report by 24LifeSciences, global stem cell therapy for diabetes and related conditions market was valued at USD 456 million in 2024 and is projected to reach USD 892 million by 2031, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 2025–2031. Stem cell therapy...0 Comentários 0 Compartilhamentos 689 Visualizações 0 Anterior
-
Global Type-2 Diabetes Components Market Trends and Forecast 2030: Growth & Market SizeThe Global Type-2 Diabetes Components Market size was valued at around USD 52.7 billion in 2024 and is expected to reach USD 72.21 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.39% during the forecast period, i.e., 2025-30. According to MarkNtel Advisors Study. Global Type-2 Diabetes Components Market Driver: Rising Global Prevalence of Obesity and...0 Comentários 0 Compartilhamentos 518 Visualizações 0 Anterior
-
SGLT2 Inhibitors Market for Diabetes Treatment Market Expands with Rising Global Burden of Diabetes and Demand for Advanced TherapiesThe Sglt2 Inhibitors Market For Diabetes Treatment Market is witnessing strong growth as the global prevalence of diabetes continues to rise and healthcare systems increasingly adopt innovative therapies that provide both glycemic control and broader metabolic benefits. Sodium-glucose cotransporter-2 inhibitors, commonly known as SGLT2 inhibitors, have become an important class of oral...0 Comentários 0 Compartilhamentos 748 Visualizações 0 Anterior
-
Why the Diabetes Care Devices Drugs Market Is Expanding Across Global HealthcareThe rising global prevalence of diabetes is driving demand for advanced diabetes care devices and medications, but the market also faces several challenges. High treatment costs, limited access to advanced therapies in developing regions, and poor patient adherence to long-term treatment plans can hinder disease management. In addition, reimbursement limitations, regulatory hurdles, and supply...0 Comentários 0 Compartilhamentos 398 Visualizações 0 Anterior
-
Basal Insulin Market to Reach $38.36 Billion by 2032Introspective Market Research (IMR) today announced its latest market intelligence report on the Global Basal Insulin Market, projecting rapid expansion over the next decade. The study indicates that the market, valued at USD 16.4 billion in 2023, is expected to reach USD 38.36 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.9% during 2024–2032. This strong growth...0 Comentários 0 Compartilhamentos 5K Visualizações 0 Anterior
-
Biologics in Spine Surgery Market: Transforming Spinal Fusion and Regenerative CareThe Biologics in Spine Surgery Market has emerged as a transformative force in orthopedic and neurosurgical care, providing innovative biological solutions that enhance spinal fusion, promote bone healing, and improve patient outcomes. This specialized market encompasses a range of products, including bone morphogenetic proteins (BMPs), platelet-rich plasma (PRP), stem cells, growth...0 Comentários 0 Compartilhamentos 8K Visualizações 0 Anterior
-
Blood Glucose Monitoring Market: $28.82B by 2032, Driven by Rising Diabetes Prevalence.Introspective Market Research (IMR) today released its latest market intelligence report on the Global Blood Glucose Monitoring Market, forecasting strong and sustained growth through 2032. According to the report, the market was valued at USD 16.49 billion in 2023 and is projected to reach USD 28.82 billion by 2032, at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2032. This...0 Comentários 0 Compartilhamentos 5K Visualizações 0 Anterior
-
Blood Glucose Test Strip Market: Empowering Diabetes Management, One Strip at a Time" According to the latest report published by Data Bridge Market Research, the Blood Glucose Test Strip Market CAGR Value Data Bridge Market Research analyses that the global blood glucose test strip market, which was USD 23,160.87 in 2022, will reach USD 38,035.76 Million by 2030 and is expected to undergo a CAGR of 6.1% during the forecast period. For an effectual business growth,...0 Comentários 0 Compartilhamentos 548 Visualizações 0 Anterior
-
Diabetes Treatments Market Size, Share, and Growth Forecast to 2030According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...0 Comentários 0 Compartilhamentos 5K Visualizações 0 Anterior
-
Non-Invasive Blood Glucose Monitoring Market Projected to Hit $177 Million by 2032.Introspective Market Research (IMR) today released its latest analysis of the Global Non-Invasive Blood Glucose Monitoring Device Market, forecasting substantial growth over the next decade. According to the report, the market was valued at USD 26.19 million in 2023 and is projected to reach USD 177.22 million by 2032, representing a compound annual growth rate (CAGR) of 23.67%. This rapid...0 Comentários 0 Compartilhamentos 5K Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali